NanoViricides Inc (NNVC)

[arvitar]

"One of the main reasons big pharma would never consider looking in NNVC's direction is that they have signed an agreement to pay 15 percent 'sales royalties' to Theracour on any drugs sold. In all the agreements I have been privy to, I have never seen one agreement that has paid that amount in royalties (on Sales). Big Pharma is accustomed to paying 9 to 12 percent which is not even enough to cover the Theracour royalties. There is nothing left for NNVC.

I have reviewed several emails where NNVC claimed that the agreement with Theracour was strictly to prevent a hostile takeover and to protect the intellectual property. If that were the case then what is the 15 percent royalty for? Let alone the 30 percent markup on everything that Theracour bills to NNVC (including salaries). With respect to the 30 percent markup, have you read the financial statements since NNVC purchased the building from Theracour? Theracour is billing NNVC for each and every salary and there is not one mention of what NNVC is getting from Theracour to use it's facility and equipment.

Now why would anyone pay out 10 million dollars for a facility and equipment and let another company come in and use it free of charge and then pay that company and it's employees (plus 30 percent I might add)? ...



All in all, I could go on forever pointing out the total gibberish in the companies recent filing which I suspect will all come to light in several months when the company has yet another excuse as to why nothing has been delivered (Herpecide should have been delivered months ago). There is a reason Big Pharma is not interested, for the reasons above and many other reasons, NNVC is worthless. Always has been. "



A very insightful and prescient analysis I found posted elsewhere on the internet, from about one year ago.